Abstract
Introduction: Surgery followed by adjuvant chemotherapy (aCT) is the standard of care for resectable pancreatic ductal adenocarcinoma (PDAC). Elderly patients (EP) may be less likely to receive aCT compared to younger patients (YP) due to comorbidities and frailty. The impact of age on the curative management and outcomes of patients with resected PDAC was investigated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
